trending Market Intelligence /marketintelligence/en/news-insights/trending/VrlAAYroefsjtEUIlsJzVA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Aptose Biosciences prices C$18.5M underwritten public offering


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

Aptose Biosciences prices C$18.5M underwritten public offering

Aptose Biosciences Inc. priced its planned underwritten public offering of 10 million common shares at C$1.85 apiece to raise C$18.5 million.

The company has granted the underwriters a 30-day option to purchase up to 1.5 million additional shares. The offering is expected to close June 3.

Toronto, Ontario-based Aptose plans to use the net proceeds to accelerate and expand its clinical trial programs, as well as for working capital and general corporate purposes.

RBC Capital Markets and Canaccord Genuity are acting as joint book-running managers, while H.C. Wainwright & Co. and JonesTrading Institutional Services LLC are acting as co-managers for the offering.